Evidence map›Paper›PMID 30411608›Full record

ArticleACS infectious diseases2019

Clostridium difficile ClpP Homologues are Capable of Uncoupled Activity and Exhibit Different Levels of Susceptibility to Acyldepsipeptide Modulation.

Nathan P Lavey, Tyler Shadid, Jimmy D Ballard, Adam S Duerfeldt

Abstract read
In one paragraph

Article in ACS infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Effect of Pefloxacin onAntibiotics (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. The small acid-soluble proteins ofbioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Ureadepsipeptides as ClpP Activators.ACS infectious diseases · 2019
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nathan P LaveyInstitute for Natural Products Applications and Research Technologies and Department of Chemistry & Biochemistry , University of Oklahoma , 101 Stephenson Parkway, Stephenson Life Sciences Research Center , Norman , Oklahoma 73019 , United States.
Tyler ShadidDepartment of Microbiology & Immunology , University of Oklahoma Health Sciences Center , 940 Stanton L. Young Boulevard , Oklahoma City , Oklahoma 73014 , United States.
Jimmy D BallardDepartment of Microbiology & Immunology , University of Oklahoma Health Sciences Center , 940 Stanton L. Young Boulevard , Oklahoma City , Oklahoma 73014 , United States.
Adam S DuerfeldtInstitute for Natural Products Applications and Research Technologies and Department of Chemistry & Biochemistry , University of Oklahoma , 101 Stephenson Parkway, Stephenson Life Sciences Research Center , Norman , Oklahoma 73019 , United States.ORCID 0000-0002-3130-9890
University of Oklahoma · USUniversity of Oklahoma Health Sciences Center · US

Funding

Structure-Function Studies of MsvR, a Methanogen-Specific Transcriptional RegulaP20GM103640 · NIGMS · UNIVERSITY OF OKLAHOMA · PI MOOERS, BLAINE H. M. · 2012 to 2021
$20.4M
Differential Effects of TcdB1 and TcdB2 in C. difficile diseaseR01AI119048 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BALLARD, JIMMY D. · 2015 to 2024
$3.8M
NIAID NIH HHS R01 AI119048NIGMS NIH HHS P20 GM103640
6 · The paper itself

Abstract

Caseinolytic protease P (ClpP) has emerged as a promising new target for antibacterial development. While ClpPs from single isoform expressing bacteria have been studied in detail, the function and regulation of systems with more than one ClpP homologue are still poorly understood. Herein, we present fundamental studies toward understanding the ClpP system in C. difficile, an anaerobic spore-forming pathogen that contains two chromosomally distant isoforms of ClpP. Examination of proteomic and genomic data suggest that ClpP1 is the primary isoform responsible for normal growth and virulence, but little is known about the function of ClpP2 or the context required for the formation of functional proteases. For the first time in a pathogenic bacterium, we demonstrate that both isoforms are capable of forming operative proteases. Interestingly, ClpP1 is the only homologue that possesses characteristic response to small molecule acyldepsipeptide activation. On the contrary, both ClpP1 and ClpP2 respond to cochaperone activation to degrade an ssrA-tagged substrate. These observations indicate that ClpP2 is less susceptible to acyldepsipeptide activation but retains the ability to interact with a known cochaperone. Homology models reveal no obvious characteristics that would allow one to predict less efficient acyldepsipeptide binding. The reported findings establish the uniqueness of the ClpP system in C. difficile, open new avenues of inquiry, and highlight the importance of more detailed structural, genetic, and biological characterization of the ClpP system in C. difficile.

Indexed as

Clostridioides difficileDepsipeptidesEndopeptidase ClpGene Expression Regulation, BacterialIsoenzymesProteolysisProteomicsSequence Homology, Amino AcidVirulenceDepsipeptidesEndopeptidase ClpIsoenzymesacyldepsipeptideATP-dependent proteasebacterial pathogenesisresistanceserine protease

Identifiers

PMID30411608
PMCPMC6497155
OpenAlexW2899928082

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.